Funded Tech Companies
Aplagon
Researching who provided funding to Aplagon? European Innovation Council Fund and Innovestor Ventures put venture money into this innovative biopharmaceutical company.
Company Overview
Company Name
Aplagon
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Tukholmankatu 8 A
Helsinki, 00290
Finland
Helsinki, 00290
Finland
Phone
Website
Email Address
Company Background Information
Overview
Aplagon is a clinical-stage biopharmaceutical company developing first-in-class therapeutics for a wide range of thromboinflammatory diseases. Aplagon is based on pioneering research on mast cell-derived heparin proteoglycans (HEP-PG) performed by Prof. Riitta Lassila's group at Wihuri Research Institute in Helsinki, Finland.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/3/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Aki Prihti
Chief Scientific Officer
Riitta Lassila
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs